NSUN2 and triple-negative breast carcinoma: In triple-negative breast cancer (TNBC), changes in the expression of m5C RNA methylation regulators, with upregulation of NSUN2 and downregulation of NSUN6, can significantly predict clinical prognosis risk in TNBC patients.